FDA's Overton Era, China Biotech From Shanghai: Readout LOUD Goes — SkimNews
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- "The Readout LOUD" podcast goes international this week, with STAT's Jason Mast joining from Shanghai to examine what the rise of Chinese drug development means for the biotech industry
- Heidi Overton is the president's pick to be commissioner of the Food and Drug Administration, a topic explored on the episode by STAT colleague Margaret Manto
- The episode frames the central question of whether Overton will bring needed stability or further controversy to what the hosts call "the troubled agency"
- The podcast's hosts — Elaine Chen, Adam Feuerstein, and Allison DeAngelis — also point listeners to separate STAT coverage on Overton's views on China, the ITM and Telix merger, and osteoporosis
Why it matters: The episode spotlights two storylines — Overton's nomination as FDA commissioner and Shanghai's biotech surge — and frames the central uncertainty itself: whether Overton delivers stability or more controversy for an agency the hosts describe as troubled, a question that will ripple into every drug-approval pipeline she touches.
Ask SkimNews
